50 results on '"Verónica Escudero"'
Search Results
2. Experiencia con inhibidores PCSK9 desde una consulta de Nefrología
- Author
-
Verónica Escudero Quesada, Jonay Pantoja Pérez, Cristina Castro Alonso, July Vanessa Osma Capera, Alejandro Valero Antón, and Asunción Sancho Calabuig
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2024
- Full Text
- View/download PDF
3. Detección de nefrotóxicos y ajuste de dosis en pacientes con filtrado glomerular bajo realizado en farmacia comunitaria: metodología
- Author
-
Gema Escribá-Martí, Iker Cámara-Ramos, María Teresa Climent-Catalá, Verónica Escudero-Quesada, and Luis Salar-Ibáñez
- Subjects
enfermedad renal crónica ,ajuste de dosis ,nefrotóxico ,farmacia comunitaria ,Pharmacy and materia medica ,RS1-441 - Abstract
La enfermedad renal crónica es un problema prevalente y sin tratamiento específico. La detección temprana es importante, siendo el Filtrado Glomerular estimado (FGe) una prueba muy asequible que puede realizarse en farmacia comunitaria. Si se presenta, es muy importante no dañar más el riñón evitando el uso de medicamentos nefrotóxicos y ajustar las dosis de otros medicamentos de eliminación renal, y la farmacia comunitaria está muy bien posicionada para ello. Objetivo: describir la metodología utilizada para detectar nefrotóxicos y ajustar dosis de otros medicamentos en farmacia comunitaria para su posterior derivación a atención primaria. Método: estudio experimental de seguimiento no controlado multicéntrico realizado en farmacias comunitarias de 4 comunidades autónomas de España. Se incluyen pacientes que cumplen criterios de inclusión y firman el consentimiento informado. Se estudian aquellos con FGe
- Published
- 2023
- Full Text
- View/download PDF
4. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes
- Author
-
Marta Araujo-Castro, Miguel Paja Fano, Begoña Pla Peris, Marga González Boillos, Eider Pascual-Corrales, Ana María García-Cano, Paola Parra Ramírez, Patricia Martín Rojas-Marcos, Jorge Gabriel Ruiz-Sanchez, Almudena Vicente, Emilia Gómez-Hoyos, Rui Ferreira, Iñigo García Sanz, Mónica Recasens, Rebeca Barahona San Millan, María José Picón César, Patricia Díaz Guardiola, Carolina Perdomo, Laura Manjón, Rogelio García-Centeno, Juan Carlos Percovich, Ángel Rebollo Román, Paola Gracia Gimeno, Cristina Robles Lázaro, Manuel Morales, María Calatayud, Simone Andree Furio Collao, Diego Meneses, Miguel Antonio Sampedro Nuñez, Verónica Escudero Quesada, Elena Mena Ribas, Alicia Sanmartín Sánchez, Cesar Gonzalvo Diaz, Cristina Lamas, Raquel Guerrero-Vázquez, María del Castillo Tous, Joaquín Serrano, Theodora Michalopoulou, Eva María Moya Mateo, and Felicia Hanzu
- Subjects
primary aldosteronism ,autonomous cortisol secretion ,dexamethasone suppression test ,cardiometabolic profile ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Purpose: The aim of this study was to evaluate the prevalence of autonomous cortisol secretion (ACS) in patients with primary aldosteronism (PA) and its implications on cardiometabolic and surgical outcomes. Methods: This is a retrospective multicenter study of PA patients who underwent 1 mg dexamethasone-suppression test (DST) during diagnostic workup in 21 Spanish tertiary hospitals. ACS was defined as a cortisol post-DST >1.8 μg/dL (confirmed ACS if >5 μg/dL and possible ACS if 1.8–5 μg/dL) in the absence of spe cific clinical features of hypercortisolism. The cardiometabolic profile was compared with a control group with ACS without PA (ACS group) matched for age and DST levels. Results: The prevalence of ACS in the global cohort of patients with PA (n = 176) was 29% (ACS–PA; n = 51). Ten patients had confirmed ACS and 41 possible ACS. The cardiometabolic profile of ACS–PA and PA-only patients was simil ar, except for older age and larger tumor size of the adrenal lesion in the ACS–PA group. When comparing the ACS–PA group (n = 51) and the ACS group (n = 78), the prevalence of hypertension (OR 7.7 (2.64–22.32)) and cardiovascular events (OR 5.0 (2.29–11.07)) was higher in ACS–PA patients than in ACS patients. The coexistence of ACS in patien ts with PA did not affect the surgical outcomes, the proportion of biochemical cure and clinical cure being similar between ACS–PA and PA-only groups. Conclusion: Co-secretion of cortisol and aldosterone affects almost one-thi rd of patients with PA. Its occurrence is more frequent in patients with larger tumors and advanced age. However, the cardiometabolic and surgical outcomes of patients with ACS–PA and PA-only are similar.
- Published
- 2023
- Full Text
- View/download PDF
5. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
- Author
-
Marta Araujo-Castro, Paola Parra, Patricia Martín Rojas-Marcos, Miguel Paja Fano, Marga González Boillos, Eider Pascual-Corrales, Ana María García Cano, Jorge Gabriel Ruiz-Sanchez, Almudena Vicente Delgado, Emilia Gómez Hoyos, Rui Ferreira, Iñigo García Sanz, Mònica Recasens Sala, Rebeca Barahona San Millan, María José Picón César, Patricia Díaz Guardiola, Carolina M. Perdomo, Laura Manjón-Miguélez, Rogelio García Centeno, Ángel Rebollo Román, Paola Gracia Gimeno, Cristina Robles Lázaro, Manuel Morales-Ruiz, María Calatayud, Simone Andree Furio Collao, Diego Meneses, Miguel Sampedro Nuñez, Verónica Escudero Quesada, Elena Mena Ribas, Alicia Sanmartín Sánchez, Cesar Gonzalvo Diaz, Cristina Lamas, María del Castillo Tous, Joaquín Serrano Gotarredona, Theodora Michalopoulou Alevras, Eva María Moya Mateo, and Felicia A. Hanzu
- Subjects
primary aldosteronism ,familial hyperaldosteronism ,genetic study ,pathogenic variant ,plasma aldosterone concentration ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
PurposeTo compare the clinical and hormonal characteristics of patients with familial hyperaldosteronism (FH) and sporadic primary aldosteronism (PA).MethodsA systematic review of the literature was performed for the identification of FH patients. The SPAIN-ALDO registry cohort of patients with no suspicion of FH was chosen as the comparator group (sporadic group).ResultsA total of 360 FH (246 FH type I, 73 type II, 29 type III, and 12 type IV) cases and 830 sporadic PA patients were included. Patients with FH-I were younger than sporadic cases, and women were more commonly affected (P = 0.003). In addition, the plasma aldosterone concentration (PAC) was lower, plasma renin activity (PRA) higher, and hypokalemia (P < 0.001) less frequent than in sporadic cases. Except for a younger age (P < 0.001) and higher diastolic blood pressure (P = 0.006), the clinical and hormonal profiles of FH-II and sporadic cases were similar. FH-III had a distinct phenotype, with higher PAC and higher frequency of hypokalemia (P < 0.001), and presented 45 years before sporadic cases. Nevertheless, the clinical and hormonal phenotypes of FH-IV and sporadic cases were similar, with the former being younger and having lower serum potassium levels.ConclusionIn addition to being younger and having a family history of PA, FH-I and III share other typical characteristics. In this regard, FH-I is characterized by a low prevalence of hypokalemia and FH-III by a severe aldosterone excess causing hypokalemia in more than 85% of patients. The clinical and hormonal phenotype of type II and IV is similar to the sporadic cases.
- Published
- 2024
- Full Text
- View/download PDF
6. Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO)
- Author
-
Marian Goicoechea, Vicente Álvarez, Alfonso Segarra, Manuel Polaina, Guillermo Martín-Reyes, Nicolás Roberto Robles, Verónica Escudero, Cristhian Orellana, Sergio Bea Granell, Joaquín de Juan-Ribera, Milagros Fernández Lucas, Jose Maria Graña, Javier Reque, Rosa Sánchez Hernández, Santiago Villamayor, and Jose Luis Górriz
- Subjects
Evolocumab ,Hipercolesterolemia familiar ,Enfermedad cardiovascular ateroesclerótica ,c-LDL ,Unidades de nefrología ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Background and objective: To describe the clinical characteristics, the reasons for initiating therapy and the effects of treatment in the initial phase of evolocumab availability in the Nephrology Units of Spain. Material and Methods: Retrospective, observational and multicentric study that included patients initiating treatment with evolocumab (from February 2016 to August 2018), in 15 Nephrology Units in Spain. The demographic and clinical characteristics of the patients, the lipid lowering treatment and the evolution of the lipid profiles between 24 weeks pre-initiation and 12 ± 4 weeks post-initiation of evolocumab were reviewed. Results: 60 patients were enrolled: 53.3% women; mean (SD) age, 56.9 (12.8) years, 45.0% with familial hypercholesterolemia (FH) (5.0% homozygous and 40.0% heterozygous) and 65.0% with atherosclerotic cardiovascular disease. The mean (SD) eGFR was 62.6 (30.0) ml/min/1.73 m2 (51.7% of patients had eGFR 2]), 50.0% had proteinuria (>300 mg/g) and 10.0% had nephrotic syndrome. Other CV risk factors were hypertension (75.0%), diabetes (25.0%), and smoking (21.7%). A 40.0% of patients were statin intolerant. At evolocumab initiation, 41.7% of patients were on a high intensity statin, 18.3% on moderate intensity statin and 50.0% were receiving ezetimibe. Mean (SD) LDL-c at evolocumab initiation was 179.7 (62.9) mg/dL (53.4% of patients with LDL-c ≥160 mg/dL and 29.3% ≥190 mg/dL). After 12 weeks, evolocumab resulted in LDL-c reductions of 60.1%. At week 12, 90.0% of patients reached LDL-c levels 2) and secondary prevention, with LDL-c levels above those recommended by the guidelines. Evolocumab used in clinical practice significantly reduced the LDL-c levels in all patients included in the study. Resumen: Antecedentes y objetivo: Describir las características clínicas de los pacientes tratados con evolocumab, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades de Nefrología de España. Material y Métodos: Estudio retrospectivo, observacional, y multicéntrico que incluye los pacientes que iniciaron tratamiento con evolocumab (desde febrero 2016 a agosto 2018), en 15 unidades de Nefrología en España. Se revisaron las características demográficas y clínicas de los pacientes, el tratamiento hipolipemiante y la evolución de los perfiles lipídicos entre 24 semanas antes y 12 ± 4 semanas después del inicio de evolocumab. Resultados: Se incluyeron 60 pacientes: 53,3% mujeres, edad media (DE) de 56,9 (12,8) años, 45,0% con hipercolesterolemia familiar (HF) (5,0% homocigota y 40,0% heterocigota), y 65,0% con enfermedad cardiovascular aterosclerótica (ECVA) previa. El filtrado glomerular estimado (FGe) medio fue 62,6 (30,0) ml/min/1,73 m2 (51,7% pacientes con FGe2]), 50,0% proteinuria (>300 mg/g) y 10,0% síndrome nefrótico. Otros factores de riesgo CV fueron: hipertensión (75,0%), diabetes mellitus (25,0%) y hábito tabáquico (21,7%). El 40,0% eran intolerantes a estatinas. Al inicio de evolocumab, el 41,7% tomaban estatinas de alta intensidad, el 18,3% estatinas de moderada intensidad y el 50,0% ezetimiba. Los niveles medios (DE) de c-LDL al inicio de evolocumab fueron de 179,7 (62,9) mg/dL (53,4% pacientes con c-LDL≥160 mg/dL y 29,3% ≥190 mg/dL). Después de 12 semanas del tratamiento con evolocumab se observó una reducción de los niveles de c-LDL del 60,1%. A la semana 12, el 90,0% de pacientes alcanzó niveles c-LDL 2) y prevención secundaria, con niveles de c-LDL muy por encima de los recomendados por las guías. Evolocumab utilizado en práctica clínica, redujo significativamente los niveles de c-LDL en todos los pacientes incluidos en el estudio.
- Published
- 2022
- Full Text
- View/download PDF
7. Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España (RETOSS-NEFRO)
- Author
-
Marian Goicoechea, Vicente Álvarez, Alfonso Segarra, Manuel Polaina, Guillermo Martín-Reyes, Nicolás Roberto Robles, Verónica Escudero, Cristhian Orellana, Sergio Bea Granell, Joaquín de Juan-Ribera, Milagros Fernández Lucas, Jose Maria Graña, Javier Reque, Rosa Sánchez Hernández, Santiago Villamayor, and Jose Luis Górriz
- Subjects
Evolocumab ,Familial hypercholesterolemia ,Atherosclerotic cardiovascular disease ,LDL-c ,Nephrology units ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Resumen: Antecedentes y objetivo: Describir las características clínicas de los pacientes tratados con evolocumab, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades de nefrología de España. Material y métodos: Estudio retrospectivo, observacional y multicéntrico que incluye los pacientes que iniciaron tratamiento con evolocumab (desde febrero de 2016 a agosto de 2018) en 15 unidades de nefrología en España. Se revisaron las características demográficas y clínicas de los pacientes, el tratamiento hipolipemiante y la evolución de los perfiles lipídicos entre 24 semanas antes y 12 ± 4 semanas después del inicio de evolocumab. Resultados: Se incluyeron 60 pacientes: 53,3% mujeres, edad media (DE) de 56,9 (12,8) años, el 45,0% con hipercolesterolemia familiar (HF) (5,0% homocigota y 40,0% heterocigota) y el 65,0% con enfermedad cardiovascular aterosclerótica (ECVA) previa. El filtrado glomerular estimado (FGe) medio fue de 62,6 (30,0) ml/min/1,73 m2 (51,7% pacientes con FGe 2]), el 50,0% con proteinuria (> 300 mg/g) y el 10,0% con síndrome nefrótico. Otros factores de riesgo CV fueron: hipertensión (75,0%), diabetes mellitus (25,0%) y hábito tabáquico (21,7%). El 40,0% eran intolerantes a estatinas. Al inicio de evolocumab, el 41,7% tomaban estatinas de alta intensidad, el 18,3% estatinas de moderada intensidad y el 50,0% ezetimiba. Los niveles medios (DE) de c-LDL al inicio de evolocumab fueron de 179,7 (62,9) mg/dl (53,4% pacientes con c-LDL ≥ 160 mg/dl y 29,3% ≥ 190 mg/dl). Después de 12 semanas del tratamiento con evolocumab se observó una reducción de los niveles de c-LDL del 60,1%. A la semana 12, el 90,0% de los pacientes alcanzó niveles c-LDL 2) y prevención secundaria, con niveles de c-LDL muy por encima de los recomendados por las guías. Evolocumab utilizado en práctica clínica, redujo significativamente los niveles de c-LDL en todos los pacientes incluidos en el estudio. Abstract: Background and objective: To describe the clinical characteristics, the reasons for initiating therapy and the effects of treatment in the initial phase of evolocumab availability in the Nephrology Units of Spain. Material and methods: Retrospective, observational and multicentric study that included patients initiating treatment with evolocumab (from February 2016 to August 2018), in 15 Nephrology Units in Spain. The demographic and clinical characteristics of the patients, the lipid lowering treatment and the evolution of the lipid profiles between 24 weeks pre-initiation and 12 ± 4 weeks post-initiation of evolocumab were reviewed. Results: Sixty patients were enrolled: 53.3% women; mean (SD) age, 56.9 (12.8) years, 45.0% with familial hypercholesterolemia (FH) (5.0% homozygous and 40.0% heterozygous) and 65.0% with atherosclerotic cardiovascular (CV) disease. The mean (SD) eGFR was 62.6 (30.0) ml/min/1.73 m2 (51.7% of patients had eGFR 2]), 50.0% had proteinuria (>300 mg/g) and 10.0% had nephrotic syndrome. Other CV risk factors were hypertension (75.0%), diabetes (25.0%), and smoking (21.7%). A 40.0% of patients were statin intolerant. At evolocumab initiation, 41.7% of patients were on a high-intensity statin, 18.3% on moderate intensity statin and 50.0% were receiving ezetimibe. Mean (SD) LDL-c at evolocumab initiation was 179.7 (62.9) mg/dL (53.4% of patients with LDL-c≥160 mg/dL and 29.3%≥190 mg/dL). After 12 weeks, evolocumab resulted in LDL-c reductions of 60.1%. At week 12, 90.0% of patients reached LDL-c levels 2) and secondary prevention, with LDL-c levels above those recommended by the guidelines. Evolocumab used in clinical practice significantly reduced the LDL-c levels in all patients included in the study.
- Published
- 2022
- Full Text
- View/download PDF
8. Graft survival differences in kidney transplants related to recipient sex and age
- Author
-
Asuncion Sancho, Eva Gavela, Julia Kanter, Sandra Beltrán, Cristina Castro, Verónica Escudero, Jonay Pantoja, Pablo Molina, Belen Vizcaíno, Mercedes González, Emma Calatayud, and Ana Avila
- Subjects
gender disparities ,kidney transplantation ,female recipients ,graft survival ,patient survival ,Medicine (General) ,R5-920 - Abstract
BackgroundIn recent years, there has been increasing interest in studying differences in recipient sex in renal disease treatment, access to renal replacement therapy, and subsequent outcomes. Our aim was to find out whether there are differences in outcomes after renal transplantation between female and male kidney transplant recipients in our series, particularly in adults under 60 years of age during long-term follow-up.MethodsThis was a retrospective study of our kidney transplant series (n = 1,101) to compare graft survival depending on the sex of the recipient in the entire series and patients < 60 years of age (n = 687) during long-term follow-up.ResultsWe observed no association between recipient sex and graft survival throughout the series, regardless of recipient sex. However, adult female recipients under 60 years of age had lower graft survival than male recipients (p = 0.040). Pre-transplant sensitization (HR 2.438, p = 0.002) and donor age (HR: 1.021, p = 0.017) were the independent variables associated with graft failure.ConclusionFemale recipients younger than 60 years of age had lower graft survival than male recipients, although there were no gender differences in graft or patient survival in the overall study population. Recipient sex per se was not related to graft failure, but the greater immunological risk in women and more frequent use of expanded criteria donors in female recipients under 60 years of age were the main factors related to their poorer graft survival. Further studies and new strategies are needed to identify these differences and develop the best approach to address them.
- Published
- 2022
- Full Text
- View/download PDF
9. Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
- Author
-
Gema Escribá-Martí, Iker Cámara-Ramos, María Teresa Climent-Catalá, Verónica Escudero-Quesada, and Luis Salar-Ibáñez
- Subjects
Medicine ,Science - Abstract
IntroductionChronic kidney disease (CKD) is a major health problem. Early detection is the key to reducing morbidity and mortality, but it is difficult because it occurs without symptoms. Diagnosis of CKD is also important to avoid nephrotoxic drugs and to adjust the doses of other medications that may be affected. Pharmacies, due to their proximity to the population, frequency of patient visits, and knowledge of medication use are an ideal location for point-of-care diagnosis or CKD.ObjectiveTo detect and refer to the primary care physician patients with low estimated glomerular filtration rate (eGFR) who use nephrotoxic drugs or who may require a dose adjustment.MethodologyPharmacy users over 60 years of age who agreed to participate were given a creatinine/eGFR test with a point-of-care meter. The eGFR was calculated and if it was less than 60 ml/min/1.73 m2, their medications were evaluated to identify nephrotoxic drugs or drugs that potentially required adjustment. If either were found, they were referred to their doctor for further management.Results198 patients were recruited in 4 pharmacies, of which 87 (43.9%) had an eGFR less than 60 ml/min/1.73 m2. They were taking a total of 635 medications. Of these 635 medications, 50 (7.9%) were affected by kidney function. Dose adjustment was recommended in 31 and discontinuation in 19. The primary care doctor accepted the recommendations for 14 medications: dose adjustment for 6 and withdrawal in 8. This represents 2.3% of medications taken by patients with an eGFR less than 60 ml/min/1.73 m2. The 50 medications identified were taken by 29 patients (33.3% of the 87 with a low eGFR) and a change in treatment was generated in 9 patients, representing 4.6% of the total number of patients in the sample, and 10% of the patients with a low eGFR.ConclusionPoint-of-care testing for kidney function in a pharmacy setting is feasible and identifies a significant number of patients with eGFR under 60 ml/min/1.73 m2. It also allows for appropriate medication management recommendations in this patient group.
- Published
- 2022
- Full Text
- View/download PDF
10. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register
- Author
-
Ramírez, Paola Parra, primary, Marcos, Patricia Martín Rojas, additional, Fano, Miguel Paja, additional, Boillos, Marga González, additional, Peris, Begoña Pla, additional, Pascual-Corrales, Eider, additional, Cano, Ana María García, additional, Ruiz-Sanchez, Jorge Gabriel, additional, Delgado, Almudena Vicente, additional, Hoyos, Emilia Gómez, additional, Ferreira, Rui, additional, Sanz, Iñigo García, additional, Sala, Mònica Recasens, additional, Millan, Rebeca Barahona San, additional, César, María José Picón, additional, Guardiola, Patricia Díaz, additional, Perdomo, Carolina María, additional, Manjón-Miguélez, Laura, additional, Centeno, Rogelio García, additional, Percovich, Juan Carlos, additional, Román, Ángel Rebollo, additional, Gimeno, Paola Gracia, additional, Lázaro, Cristina Robles, additional, Ruiz, Manuel Morales, additional, Calatayud, María, additional, Collao, Simone Andree Furio, additional, Meneses, Diego, additional, Nuñez, Miguel Antonio Sampedro, additional, Quesada, Verónica Escudero, additional, Ribas, Elena Mena, additional, Sánchez, Alicia Sanmartín, additional, Diaz, César Gonzalvo, additional, Oliveira, Cristina Lamas, additional, Guerrero-Vázquez, Raquel, additional, Tous, María Del Castillo, additional, Gotarredona, Joaquín Serrano, additional, Alevras, Theodora Michalopoulou, additional, Mateo, Eva María Moya, additional, Hanzu, Felicia Alexandra, additional, and Araujo-Castro, Marta, additional
- Published
- 2023
- Full Text
- View/download PDF
11. The Geographical Dimension of Inequalities in Access to Employment
- Author
-
Philippe ASKENAZY and Verónica ESCUDERO
- Published
- 2022
- Full Text
- View/download PDF
12. Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España (RETOSS-NEFRO)
- Author
-
Verónica Escudero, José M. Graña, Milagros Fernández Lucas, Rosa Sánchez Hernández, Vicente Álvarez, Alfonso Segarra, Guillermo Martín-Reyes, Javier Reque, José Luis Górriz, Nicolás Roberto Robles, Marian Goicoechea, Manuel Polaina, Santiago Villamayor, Sergio Bea Granell, Cristhian Orellana, and Joaquín de Juan-Ribera
- Subjects
Gynecology ,medicine.medical_specialty ,Evolocumab ,medicine.diagnostic_test ,Nephrology ,Atherosclerotic cardiovascular disease ,business.industry ,Medicine ,business ,Lipid profile - Abstract
Resumen Antecedentes y objetivo Describir las caracteristicas clinicas de los pacientes tratados con evolocumab, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades de nefrologia de Espana. Material y metodos Estudio retrospectivo, observacional y multicentrico que incluye los pacientes que iniciaron tratamiento con evolocumab (desde febrero de 2016 a agosto de 2018) en 15 unidades de nefrologia en Espana. Se revisaron las caracteristicas demograficas y clinicas de los pacientes, el tratamiento hipolipemiante y la evolucion de los perfiles lipidicos entre 24 semanas antes y 12 ± 4 semanas despues del inicio de evolocumab. Resultados Se incluyeron 60 pacientes: 53,3% mujeres, edad media (DE) de 56,9 (12,8) anos, el 45,0% con hipercolesterolemia familiar (HF) (5,0% homocigota y 40,0% heterocigota) y el 65,0% con enfermedad cardiovascular aterosclerotica (ECVA) previa. El filtrado glomerular estimado (FGe) medio fue de 62,6 (30,0) ml/min/1,73 m2 (51,7% pacientes con FGe 2]), el 50,0% con proteinuria (> 300 mg/g) y el 10,0% con sindrome nefrotico. Otros factores de riesgo CV fueron: hipertension (75,0%), diabetes mellitus (25,0%) y habito tabaquico (21,7%). El 40,0% eran intolerantes a estatinas. Al inicio de evolocumab, el 41,7% tomaban estatinas de alta intensidad, el 18,3% estatinas de moderada intensidad y el 50,0% ezetimiba. Los niveles medios (DE) de c-LDL al inicio de evolocumab fueron de 179,7 (62,9) mg/dl (53,4% pacientes con c-LDL ≥ 160 mg/dl y 29,3% ≥ 190 mg/dl). Despues de 12 semanas del tratamiento con evolocumab se observo una reduccion de los niveles de c-LDL del 60,1%. A la semana 12, el 90,0% de los pacientes alcanzo niveles c-LDL Conclusiones En las unidades de nefrologia de Espana, evolocumab se ha prescrito principalmente en pacientes con HF, enfermedad renal cronica (ERC > 2) y prevencion secundaria, con niveles de c-LDL muy por encima de los recomendados por las guias. Evolocumab utilizado en practica clinica, redujo significativamente los niveles de c-LDL en todos los pacientes incluidos en el estudio.
- Published
- 2022
- Full Text
- View/download PDF
13. What has been driving work-to-work transitions in the emerging world? : a comparative study of Indonesia and South Africa
- Author
-
Johannes Brehm, Angela Doku, and Verónica Escudero
- Abstract
This paper examines these elements in the context of South Africa and Indonesia– two middle-income countries with similar development levels yet different labour market characteristics. We employ a comparative cross-country methodology using long-term panel data.
- Published
- 2023
- Full Text
- View/download PDF
14. Dimension géographique des inégalités d’accès à l’emploi
- Author
-
Philippe ASKENAZY and Verónica ESCUDERO
- Abstract
En analysant le poids des processus géographiques à l’œuvre sur les inégalités interindividuelles d’accès à l’emploi dans ses différentes dimensions, ce chapitre recense une multiplicité de mécanismes socio-économiques confortés par une imposante littérature empirique tant en géographie, économie que sociologie. Ils interrogent et souvent réfutent la pertinence des hypothèses et les prédictions des principales formalisations théoriques.
- Published
- 2022
- Full Text
- View/download PDF
15. Experiencia con inhibidores PCSK9 desde una consulta de Nefrología
- Author
-
Verónica Escudero Quesada, Jonay Pantoja Pérez, Cristina Castro Alonso, July Vanessa Osma Capera, Alejandro Valero Antón, and Asunción Sancho Calabuig
- Subjects
Nephrology - Published
- 2022
- Full Text
- View/download PDF
16. How Impact Evaluation Is Shaping the Design of Labour Market Policies
- Author
-
Verónica Escudero
- Published
- 2022
- Full Text
- View/download PDF
17. Why Should We Integrate Income and Employment Support? A Conceptual and Empirical Investigation
- Author
-
Antonia Asenjo, Verónica Escudero, and Hannah Liepmann
- Subjects
History ,Polymers and Plastics ,Business and International Management ,Industrial and Manufacturing Engineering - Published
- 2022
- Full Text
- View/download PDF
18. Monitoreo microbiológico para la gestión ambiental de Aguas Residuales Hospitalarias
- Author
-
Mayra Verónica Escudero Vilema, Silvana Natali Córdova Morales, Carlos Rolando Rosero Erazo, and Andrés Agustín Beltrán Dávalos
- Subjects
Biology ,Molecular biology - Abstract
El estudio microbiológico para evaluar patógenos en aguas residuales de la unidad Hospitalaria General Puyo se desarrolló en los laboratorios de análisis bioquímicos y bacteriológicos de la Facultad de Ciencias de la Escuela Superior Politécnica de Chimborazo. Durante tres meses se recolectó 6 muestras compuestas con sus respectivas réplicas antes y después de la Planta de tratamiento de Aguas Residuales (PTAR) realizando análisis físico – químico como: pH, Conductividad, salinidad, sólidos disueltos totales, turbiedad, color, DBO5, DQO, seguido de un análisis microbiológico mediante siembras de vertido en placa para la identificación y cuantificación de bacterias: Escherichia Coli, Staphylococcus aureus y Salmonellas spp .y finalmente se realizó la Tinción Gram previo a realizar las pruebas bioquímicas donde se identificaron una totalidad de Bacilos Gram negativos, las bacterias identificadas fueron de la familia Enterobacteriaceae. Identificando las siguientes familias, Escherichia coli, (50%), Klebsiella pneumoniae, (10%) Enterobacter cloacae (0,1%) Shigella dysenteriae, (10%) Salmonella spp (30 %), concluyendo así que las aguas residuales provenientes de esta unidad Hospitalaria tienen un porcentaje de toxicidad alta y los tratamientos convencionales de aguas residuales no eliminan la su toxicidad biológica
- Published
- 2019
- Full Text
- View/download PDF
19. Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study
- Author
-
Elena Gimenez-Civera, Luis M Pallardó, Verónica Escudero, Mariola D Molina, Pilar Sánchez-Pérez, Ana Peris, Luis D'Marco, Luis Álvarez, Miguel Gonzalez-Rico, Jose E. Fernandez-Najera, María Jesús Puchades, José Luis Górriz, Javier Torralba, Pablo Molina, Juan Jesus Carrero, Universidad de Alicante. Departamento de Matemáticas, Bioquímica Aplicada/Applied Biochemistry (AppBiochem), and Grupo de Estadística Aplicada (GESTA)
- Subjects
Nephrology ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,030232 urology & nephrology ,Phosphate ,030204 cardiovascular system & hematology ,Gastroenterology ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Renal Dialysis ,Estadística e Investigación Operativa ,Internal medicine ,Chronic kidney disease ,medicine ,Humans ,Prospective Studies ,Renal Insufficiency, Chronic ,education ,Survival analysis ,Dialysis ,Bone mineral ,Hyperparathyroidism ,education.field_of_study ,Minerals ,business.industry ,Proportional hazards model ,Calcium, Chronic kidney disease, Hyperparathyroidism, Phosphate, Survival analysis ,medicine.disease ,Parathyroid Hormone ,Calcium ,business ,Kidney disease - Abstract
Background Abnormalities of bone mineral parameters are associated with increased mortality in patients on dialysis, but their effects and the optimal range of these biomarkers are less well characterized in non-dialysis chronic kidney disease (CKD). Methods PECERA (Collaborative Study Project in Patients with Advanced CKD) is a 3-year, prospective multicenter, open-cohort study of 966 adult patients with non-dialyzed CKD stages 4-5 enrolled from 12 centers in Spain. Associations between levels of serum calcium (Ca) (corrected for albumin), phosphate (P), and intact parathyroid hormone (iPTH) with all-cause mortality (primary outcome) and cardiovascular mortality (secondary outcome) were examined using time-dependent Cox proportional hazards models and penalized splines analysis adjusted by demographics and comorbidities, treatments and biochemical values collected every 6 months for 3 years. Results After a median follow-up of 29 months (IQR: 13-36 months) there were 181 deaths (19%). The association of calcium with all-cause mortality was J-shaped, with an increased risk for all-cause mortality at levels > 10.5 mg/dL. For phosphate and iPTH levels, the association was U-shaped. The serum values associated with the minimum risk of mortality were 3.8 mg/dL for phosphate and 70 pg/mL for iPTH, being the lowest risk ranges between 2.8 and 5.0 mg/dL, and between 38 and 112 pg/mL for phosphate and iPTH, respectively. Conclusions Our study provides evidence on the non-linear association of serum calcium, phosphate and iPTH levels with mortality in stage 4 and 5 CKD patients, and suggests potential survival benefits for controlling bone mineral parameters in this population, as previously reported for dialysis patients.
- Published
- 2021
20. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia
- Author
-
Luis M Pallardó, Luis D'Marco, Eduardo Núñez, Irina Sanchis, Nuria Estañ, Verónica Escudero, Pablo Molina, Rafael de la Espriella, José Luis Górriz, Miguel Gonzalez-Rico, María Jesús Puchades, Anna Pastor-González, and Julio Núñez
- Subjects
Male ,medicine.medical_specialty ,Hyperkalemia ,Aftercare ,Sudden cardiac death ,Internal medicine ,Diabetes mellitus ,medicine ,Risk of mortality ,Humans ,Renal Insufficiency, Chronic ,Aged ,Aged, 80 and over ,Transplantation ,business.industry ,Sang Coagulació Factors ,Retrospective cohort study ,medicine.disease ,Patient Discharge ,Nephrology ,Heart failure ,Cardiology ,Insuficiència renal crònica ,Potassium ,medicine.symptom ,Complication ,business ,Kidney disease - Abstract
Background Hyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that is associated with a higher risk of adverse clinical events such as ventricular arrhythmias and sudden cardiac death. Currently, data regarding the prognostic implications of chronic hyperkalaemia are available; however, information about the long-term clinical consequences after an episode of severe hyperkalaemia remains scarce. The objective of this study was to evaluate the association between the trajectory of potassium measurements in patients with acute hyperkalaemia and long-term all-cause mortality. Methods This is a retrospective observational study that included patients with acute severe hyperkalaemia [potassium (K) >6 mEq/L] without haemolysis in the emergency room of Dr Peset University Hospital in Valencia, Spain searching the lab database from January 2016 to March 2017. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modelling. Results We found 172 episodes of acute hyperkalaemia in 160 patients in the emergency room. The mean ± standard deviation age of the sample was 77 ± 12 years and 60.5% were males. The most frequent comorbidities were CKD (71.2%), HF (35%) and diabetes mellitus (56.9%). Only 11.9% of the patients were on chronic dialysis. A quarter of the patients did not have previous CKD, making hyperkalaemia an unpredictable life-threatening complication. During the acute episode, mean potassium and estimated glomerular filtration rate (eGFR) were 6.6 ± 0.6 (range 6.1–9.2) mEq/L and 23 ± 16 (range 2–84) mL/min/1.73 m2, respectively. After a median (interquartile range) follow-up of 17.3 (2.2–23.7) months, 68 patients died (42.5%). Recurrences of hyperkalaemia (K >5.5 mEq/L) were detected in 39.5% of the patients who were monitored during follow-up. We found that previous potassium levels during an acute severe hyperkalaemia episode were not predictors of mortality. Conversely, the post-discharge longitudinal trajectories of potassium were able to predict all-cause mortality (overall P = 0.0015). The effect of transitioning from hyperkalaemia to normokalaemia (K >5.5 mEq/L to K ≤5.5 mEq/L) after the acute episode was significant, and inversely associated with the risk of mortality. Conclusions Potassium levels prior to a severe hyperkalaemic event do not predict mortality. Conversely, following an episode of acute severe hyperkalaemia, serial kinetics of potassium trajectories predict the risk of death. Further evidence is needed to confirm these findings and clarify the optimal long-term management of these patients.
- Published
- 2020
21. Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis
- Author
-
Luis M Pallardó, Juan F. Navarro-González, Cristina Castro-Alonso, Pablo Molina, Jaume Pomés, Jose M. Valdivielso, Luis D'Marco, José Luis Górriz, Begoña Ribas, Verónica Escudero, Monserrat Del Amo Conill, Jordi Bover, María Jesús Puchades, and Ana Isabel García-Díez
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Osteoporosis ,030232 urology & nephrology ,lcsh:Medicine ,030209 endocrinology & metabolism ,Logistic regression ,Article ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Risk factor ,Survival analysis ,Dialysis ,Vascular disease ,business.industry ,lcsh:R ,General Medicine ,fractures ,medicine.disease ,vascular calcification ,business ,chronic kidney disease ,Cohort study ,Kidney disease - Abstract
Background: The prevalence of vertebral fractures (VF) and their association with clinical risk factors and outcomes are poorly documented in chronic kidney disease (CKD) cohorts. The aim of the study was to evaluate the prevalence of VF in patients with non-dialysis dependent CKD (NDD-CKD), their value in predicting mortality and its correlation with parameters of bone mineral metabolism and vascular calcification. Materials and Methods: 612 NDD 3‒5 stage CKD patients participating in the OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into two groups according to presence or absence of VF at enrollment. VF were assessed with lateral radiographs and Genant semi-quantitative method was applied. Three radiologists specialized in musculoskeletal radiology performed consensual reading of individual images obtained using a Raim DICOM Viewer and a Canon EOS 350 camera to measure with Java Image software in those who had traditional acetate X-ray. Factors related to VF were assessed by logistic regression analysis. Association between VF and death over a 3-year follow-up was assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. Results: VF were detected in 110 patients (18%). Serum phosphate levels (OR 0.719, 95% CI 0.532 to 0.972, p = 0.032), ankle-brachial index <, 0.9 (OR 1.694, 95% CI 1.056‒2.717, p = 0.029) and treatment with bisphosphonates (OR 5.636, 95% CI 1.876‒16.930, p = 0.002) were independently related to the presence of VF. After a median follow-up of 35 months (IQR: 17‒37 months), 62 patients (10%) died. The causes of death were cardiovascular (n = 21, 34%) and infectious (n = 11, 18%). In the crude analysis, fractured patients group had poorer survival (log-rank test, p = 0.02). After multivariate adjustment for age, MDRD, albumin, diabetes mellitus, comorbidity, Adragao Score >, 3 and serum phosphate, the presence of VF (HR 1.983, 95% CI 1.009‒3.898, p = 0.047) were an independent predictor of all-cause mortality. Conclusions: In our study 18% of patients with NDD-CKD have VF. Factors associated with VF were age, low serum phosphate levels and peripheral vascular disease. The presence of VF was an independent risk factor for mortality in stages 3‒5 NDD-CKD patients. Clinical trials are needed to confirm whether this relationship is causal and reversible with treatment for osteoporosis
- Published
- 2020
22. La Garantie européenne pour la jeunesse
- Author
-
Elva López Mourelo and Verónica Escudero
- Subjects
General Medicine - Abstract
La Garantie europeenne pour la jeunesse (ou Garantie jeunesse) apparait comme une politique du marche du travail innovante. Elle a ete promue dans un contexte ou se faisait sentir le besoin d’une reponse urgente face aux consequences durablement prejudiciables du chomage de longue duree. Cet article examine les donnees empiriques sur l’efficacite des experiences anterieures de mesures ciblees sur les jeunes, ainsi que les evaluations existantes de la Garantie jeunesse, afin d’identifier les facteurs qui s’averent decisifs pour sa reussite. Il determine ensuite si ces facteurs cles de reussite sont integres dans les plans de mise en œuvre elabores par les pays europeens et regarde dans quelles mesures les objectifs fixes ont ete atteints dans la pratique. La plupart des pays ont etabli des criteres d’eligibilite clairs ainsi que des cadres institutionnels appropries et proposent un ensemble complet de mesures ; cependant, bon nombre d’entre eux ont encore des difficultes a atteindre les objectifs fixes en termes d’intervention precoce et a mettre en place des mecanismes d’execution efficaces. Enfin, bien que les sommes effectivement investies par les Etats dans les programmes nationaux de Garantie jeunesse aient souvent depasse les depenses initialement prevues, les allocations de ressources se sont souvent averees insuffisantes par rapport aux recommandations.
- Published
- 2018
- Full Text
- View/download PDF
23. Effectiveness of Active Labor Market Tools in Conditional Cash Transfers Programs: Evidence for Argentina
- Author
-
Elva López Mourelo and Verónica Escudero
- Subjects
Market integration ,Economics and Econometrics ,Labour economics ,Cash transfers ,Exit strategy ,Sociology and Political Science ,050204 development studies ,Impact evaluation ,media_common.quotation_subject ,05 social sciences ,Geography, Planning and Development ,Conditional cash transfer ,Context (language use) ,Development ,Identification (information) ,Cash ,0502 economics and business ,Economics ,050207 economics ,media_common - Abstract
Summary This paper examines the impact of the program Seguro de Capacitacion y Empleo (SCE) implemented to provide support in skills upgrading, job seeking, and job placement to eligible beneficiaries of the Argentinian conditional cash transfer program Plan Jefes. The SCE is an example of a growing trend observed in Latin America, where labor activation components have been increasingly included into cash transfers programs to support beneficiaries in finding more stable income opportunities. Despite this growing trend, not enough is known regarding the effectiveness of these components, especially on job quality. In this context, this paper sheds light on whether the provision of a comprehensive package of active labor market measures contributes to a successful labor market integration of cash transfers beneficiaries. Taking advantage of the panel structure of the Permanent Household Survey and exploiting the time variation in the assignment of the program as identification strategy, we apply difference-in-difference estimators to measure the impact on a number of labor market indicators. We find that the program affects positively the job quality of participants by increasing the probability of having a formal job and raising hourly wages. Moreover, the intervention is associated with a lower probability of having a low-paid job and working an excessive number of hours. These effects are, however, not homogeneous across all groups of participants. While the program is more successful among the younger beneficiaries, it does not contribute to an improvement in the labor market conditions of female beneficiaries, who in fact are the majority of SCE participants. Our results suggest that reducing dependency on monetary transfers through programs, such as the SCE, that are rich in activation components is beneficial for participants’ labor market trajectories and therefore, it constitutes a satisfactory exit strategy to more universal cash transfer programs.
- Published
- 2017
- Full Text
- View/download PDF
24. FP116TRAJECTORY OF POTASSIUM MEASUREMENTS IN PATIENTS WITH ACUTE SEVERE HYPERKALEMIA AND LONG-TERM ALL-CAUSE MORTALITY
- Author
-
Anna Pastor, Verónica Escudero, José Luis Górriz, Mª Jesus Puchades, Irina Sanchis, M Pallardó Luis, Pablo Molina, and Julio Núñez
- Subjects
Transplantation ,medicine.medical_specialty ,Hyperkalemia ,business.industry ,Potassium ,chemistry.chemical_element ,Term (time) ,chemistry ,Nephrology ,Internal medicine ,medicine ,Cardiology ,In patient ,medicine.symptom ,business ,All cause mortality - Published
- 2019
- Full Text
- View/download PDF
25. SP489The role of CA125 as a volume marker before and after hemodialysis session
- Author
-
Emma Calatayud, Verónica Escudero, Mercedes González-Moya, Antonio Mora, Nuria Estañ, Alba Durbá, Luis M Pallardó, Sandra Beltrán, Erika Pérez-Zafra, Belén Vizcaíno, and Pablo Molina
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,medicine.medical_treatment ,Internal medicine ,Ca 125 antigen ,Cardiology ,Medicine ,Session (computer science) ,Hemodialysis ,business ,Volume (compression) - Published
- 2019
- Full Text
- View/download PDF
26. The employment effect of changes in the composition of fiscal consolidations
- Author
-
Elva López Mourelo and Verónica Escudero
- Subjects
Macroeconomics ,Economics and Econometrics ,Fiscal imbalance ,Economic policy ,media_common.quotation_subject ,05 social sciences ,Fiscal union ,Fiscal policy ,Austerity ,Consolidation (business) ,Debt ,0502 economics and business ,Sustainability ,Economics ,Revenue ,050207 economics ,050205 econometrics ,media_common - Abstract
This paper assesses the magnitude and nature of fiscal consolidation policies and their impact on employment. In particular, in an attempt to address fiscal imbalances in the near term, countries have been faced with the delicate challenge of doing so without damaging recovery prospects and thus, counter to their original aim, worsening further public finances. In this regard, the paper reviews recent austerity measures adopted by governments and discusses how prolonging fiscal consolidation measures in their current form could be counterproductive for guaranteeing debt sustainability. Moreover, the article shows how poorly designed fiscal cuts – directly or indirectly affecting labour – seem to have been dampening job prospects. The paper sheds light on how fiscal and employment goals can be achieved together. More specifically, it finds that a fiscally-neutral change in the expenditure and revenue composition of fiscal consolidation can boost job creation. In this sense, the paper shows that it ...
- Published
- 2016
- Full Text
- View/download PDF
27. Joint provision of income and employment support: Evidence from a crisis response in Uruguay
- Author
-
Clemente. Pignatti, Elva López Mourelo, and Verónica Escudero
- Subjects
Economics and Econometrics ,Sociology and Political Science ,media_common.quotation_subject ,Impact evaluation ,Geography, Planning and Development ,Conditional cash transfer ,Development ,Recession ,Active labour market policies ,Income Support ,Social protection ,Cash ,Unemployment ,Demographic economics ,Business ,media_common - Abstract
There is an increasing recognition in the policy debate of the importance of providing support to unemployed individuals through a combination of income support and active labour market policies. However, very little evidence exists on the effectiveness of this policy approach (and possible trade-offs) beyond developed economies. We provide one of the first evaluations of these schemes in the context of an emerging economy by looking at a public works programme implemented in Uruguay between 2005 and 2007 as part of a comprehensive cash transfer intervention that reached around 10 per cent of households in the country during a major recession. Exploiting specific eligibility criteria for participation in the cash transfer programme, we use rich administrative data of panel nature to study the effects of (i) participating in the public works programme (active component), (ii) receiving the cash transfer (income-support component) and, (iii) of benefiting of both the active and income-support programmes. We find that participation in the active programme has positive (albeit only marginally significant) effects on the employment probability, but non-significant effects on the quality of the job found. The positive employment effect does not generate displacement effects from participants to non-participants within the same household. However, the effect fades away when participants receive the cash transfer. Finally, the programme did not have any effect on measures of civic engagement and social integration.
- Published
- 2020
- Full Text
- View/download PDF
28. Improving Competitiveness and Fostering Productivity in Spain
- Author
-
Elva López Mourelo and Verónica Escudero
- Subjects
Economics and Econometrics ,Geography ,Welfare economics ,Cartography ,Productivity - Abstract
espanolLa competitividad en Espana se deterioro drasticamente a lo largo de la ultima decada, motivada principalmente por una caida en la productividad laboral. No obstante, desde el comienzo de la actual crisis economica, han empezado a observarse ciertos signos de recuperacion en la productividad laboral que acompanados de las politicas correctas podrian desembocar en una mejora sostenible de la competitividad. El objetivo de este articulo es arrojar luz sobre los principales factores que explicaron el deterioro de la competitividad en Espana y describir los acontecimientos re-cientes que nos permiten pensar en una trayectoria diferente de la del crecimiento anterior a la crisis. Finalmente, el articulo presenta una serie de recomendaciones de politica que Espana deberia tener en cuenta para alcanzar una me-jora sostenible en la productividad laboral y, por lo tanto, lograr una transformacion estructural hacia un crecimiento economico mas equilibrado. EnglishCompetitiveness in Spain has deteriorated dramatically over the past decade driven mainly by a decrease in labour productivity. Since the onset of the current crisis, however, there were some signs of recovery in labour productivity, which accompanied by well design policies could lead to a sustainable improvement in competitiveness. The purpose of this paper is to shed light on the main factors that lead to the deterioration in Spain's competitiveness and describe some of the recent developments that lead us to believe that there are early signs of a departure from pre-crisis growth patterns. Finally, the paper discusses a number of policy shortcomings that Spain will need to address in order to attain a sustainable improvement in labour productivity and, therefore, make a structural transformation towards a more ba-lanced economic growth.
- Published
- 2020
- Full Text
- View/download PDF
29. Active Labour Market Programmes in Latin America and the Caribbean: Evidence from a Meta-Analysis
- Author
-
Clemente. Pignatti, Elva López Mourelo, Verónica Escudero, and Jochen Kluve
- Subjects
O54 ,Labour economics ,Youth unemployment ,Latin Americans ,Informal sector ,active labour market program ,050204 development studies ,Impact evaluation ,impact evaluation ,05 social sciences ,J24 ,J46 ,Development ,Active labour ,J08 ,Latin America and the Caribbean ,Meta-analysis ,employment ,0502 economics and business ,ddc:330 ,Economics ,informality ,050207 economics ,meta analysis - Abstract
We present a systematic collection and assessment of impact evaluations of active labour market programmes (ALMP) in Latin America and the Caribbean (LAC). The paper delineates the strategy to compile a novel meta database and provides a narrative review of 51 studies. Based on these studies, the quantitative analysis extracts a sample of 296 impact estimates, and uses meta regression models to analyse systematic patterns in the data. In addition to analysing earnings and employment outcomes as in previous meta analyses, we also code and investigate measures of job quality, such as the effects on hours worked and formality. We find that ALMPs in LAC are particularly effective in increasing the probability of having a formal job, compared to other outcomes. Our results also show that training programmes are slightly more effective than other types of interventions. Moreover, when looking at the sample of training programmes alone, we observe that formal employment is also the outcome category that is most likely to be impacted positively by these programmes. In terms of targeting, we find that ALMPs in the region work better for women than for men, and for youth compared to prime-age workers. Finally, medium-run estimates are not more likely to be positive than short-run estimates, while programmes of short duration (4 months or less) are significantly less likely to produce positive effects compared to longer interventions.
- Published
- 2018
- Full Text
- View/download PDF
30. Vascular Calcification in Patients with Nondialysis CKD over 3 Years
- Author
-
Rocío Vila, Guillermina Barril, Verónica Escudero, M. Jesús Cerverón, José Luis Górriz, Luis M. Molinero, Teresa Adragão, Juan F. Navarro-González, Luis M Pallardó, Sophie A. Jamal, Elvira Fernández, Cristina Castro-Alonso, Javier Nieto, Jordi Bover, Celestino Piñera, Alberto Martínez-Castelao, and Pablo Molina
- Subjects
Transplantation ,medicine.medical_specialty ,Epidemiology ,business.industry ,Proportional hazards model ,medicine.medical_treatment ,Hazard ratio ,Odds ratio ,Critical Care and Intensive Care Medicine ,Confidence interval ,Surgery ,Nephrology ,Predictive value of tests ,Internal medicine ,Medicine ,business ,Prospective cohort study ,Survival analysis ,Dialysis - Abstract
Background and objectives Vascular calcification (VC) is common in CKD, but little is known about its prognostic effect on patients with nondialysis CKD. The prevalence of VC and its ability to predict death, time to hospitalization, and renal progression were assessed. Design, setting, participants, & measurements The Study of Mineral and Bone Disorders in CKD in Spain is a prospective, observational, 3-year follow-up study of 742 patients with nondialysis CKD stages 3–5 from 39 centers in Spain from April to May 2009. VC was assessed using Adragao (AS; x-ray pelvis and hands) and Kauppila (KS; x-ray lateral lumbar spine) scores from 572 and 568 patients, respectively. The primary end point was death. Secondary outcomes were hospital admissions and appearance of a combined renal end point (beginning of dialysis or drop >30% in eGFR). Factors related to VC were assessed by logistic regression analysis. Survival analysis was assessed by Cox proportional models. Results VC was present in 79% of patients and prominent in 47% (AS≥3 or KS>6). Age (odds ratio [OR], 1.05; 95% confidence interval [95% CI], 1.02 to 1.07; P 6 was independently associated with all-cause (hazard ratio [HR], 2.07; 95% CI, 1.07 to 4.01; P=0.03) and cardiovascular (HR, 3.46; 95% CI, 1.27 to 9.45; P=0.02) mortality as well as a shorter hospitalization event–free period (HR, 1.14; 95% CI, 1.06 to 1.22; P Conclusions VC is highly prevalent in patients with CKD. VC assessment using AS independently predicts death and time to hospitalization. Therefore, it could be a useful index to identify patients with CKD at high risk of death and morbidity as previously reported in patients on dialysis.
- Published
- 2015
- Full Text
- View/download PDF
31. Youth Labour Market Prospects and Recent Policy Developments
- Author
-
Steven Tobin, Elva López Mourelo, Stefan Kühn, and Verónica Escudero
- Subjects
media_common.quotation_subject ,05 social sciences ,0211 other engineering and technologies ,0507 social and economic geography ,Face (sociological concept) ,021107 urban & regional planning ,Context (language use) ,02 engineering and technology ,Active labour market policies ,Job quality ,Development economics ,Unemployment ,Economics ,050703 geography ,media_common - Abstract
Youth continue to face important labour market challenges today, often significantly greater than their adult counterparts. While unemployment rates have fallen in recent years, long-term unemployment remains persistently high as does the share of youth neither in employment nor in education or training. This raises concerns about the consequences of a prolonged joblessness among youth and the role of labour market policies in addressing these challenges. In this context, this chapter presents first, an overview of global youth labour market trends since the economic crisis, focusing on the developments in Europe. Second, the chapter examines the consequences of the current situation in Europe along several dimensions, notably the risk of detachment from the labour market and concerns about job quality. Finally, this chapter discusses valuable lessons learned on the effectiveness of youth labour market policies, using the European Youth Guarantee as a framework for the analysis of more specific measures.
- Published
- 2017
- Full Text
- View/download PDF
32. Active Labour Market Programmes in Latin America and the Caribbean: Evidence from a Meta Analysis
- Author
-
Jochen Kluve, Clemente. Pignatti, Elva López Mourelo, and Verónica Escudero
- Subjects
Latin Americans ,Earnings ,Quantitative analysis (finance) ,Meta-analysis ,Impact evaluation ,Psychological intervention ,Meta-regression ,Demographic economics ,Sample (statistics) ,Psychology - Abstract
We present a systematic collection and assessment of impact evaluations of active labour market programmes (ALMP) in Latin America and the Caribbean (LAC). The paper delineates the strategy to compile a novel meta database and provides a narrative review of 51 studies. Based on these studies, the quantitative analysis extracts a sample of 296 impact estimates, and uses meta regression models to analyse systematic patterns in the data. In addition to analysing earnings and employment outcomes as in previous meta analyses, we also code and investigate measures of job quality, such as the effects on hours worked and formality.We find that ALMPs in LAC are particularly effective in increasing the probability of having a formal job, compared to other outcomes. Our results also show that training programmes are slightly more effective than other types of interventions. Moreover, when looking at the sample of training programmes alone, we observe that formal employment is also the outcome category that is most likely to be impacted positively by these programmes. In terms of targeting, we find that ALMPs in the region work better for women than for men, and for youth compared to prime-age workers. Finally, medium-run estimates are not more likely to be positive than short-run estimates, while programmes of short duration (4 months or less) are significantly less likely to produce positive effects compared to longer interventions.
- Published
- 2017
- Full Text
- View/download PDF
33. SP470RELATIONSHIP BETWEEN PREDICTIVE KT/V AND CALCULATED KT/V ACHIEVED WITH NXSTAGE CYCLER IN SHORT-DAILY HOME HEMODIALYSIS PATIENTS
- Author
-
Luis M Pallardó, Jonay Pantoja, Mariola D Molina, Belén Vizcaíno, Mercedes González-Moya, Nuria Estañ, Verónica Escudero, Antonio Mora, Irina Sanchis, Sandra Beltrán, Mari Sargsyan, and Pablo Molina
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,Kt/V ,business.industry ,Home hemodialysis ,Urology ,medicine ,business - Published
- 2018
- Full Text
- View/download PDF
34. Freud, ¿pedagogo o antipedagogo?
- Author
-
Verónica Escudero
- Abstract
espanolA partir de la afirmacion freudiana que dice que educar, psicoanalizar y gobernar son profesiones imposibles, este trabajo recorre los aportes de dos libros, Freud antipedagogo de Catherine Millot (1990) y ?Freud pedagogo? de Mireille Cifali (2003), con el proposito de examinar los desarrollos freudianos sobre las relaciones entre psicoanalisis y pedagogia. Planteado como una conversacion entre textos se tratara de situar la enunciacion propia de cada autora. EnglishOn the basis of Freudian statement that educating, psychoanalyzing and governing are im-possible professions, Freud antipedagogo by Cathe-rine Millot and?Freud pedagogo? by Mireille Cifali are traced back to explore Freudian ideas in this field. The dialogue between these two texts does not involve making them answer each other or ma-king their temporal appearance reveal an absolute truth.
- Published
- 2019
- Full Text
- View/download PDF
35. How to shift to a more equitable and job-friendly path
- Author
-
Verónica Escudero, Miguel Angel Malo, and Sameer Khatiwada
- Subjects
Social protection ,Path (graph theory) ,Economics ,Economic system - Abstract
This Chapter shows how an approach that balances macroeconomic and employment goals, while at the same time taking social impacts into account, is necessary to achieve a sustainable and inclusive recovery. Moving towards such an approach requires attention to be paid to a number of policy areas, including macroeconomic, labour market and social protection policies. In addition, this Chapter highlights a wide range of recent initiatives that have made an effort to achieve this kind of rebalancing.
- Published
- 2013
- Full Text
- View/download PDF
36. La centroizquierda en la Argentina: el Frente País Solidario (FREPASO), la Alianza y el Frente para la Victoria (FpV) -kirchnerismo
- Author
-
Laura Verónica Escudero and Llamazares Valduvieco, Iván
- Subjects
LAW/JURISPRUDENCE ,Academic dissertations ,Ciencia política ,Partidos políticos ,Liderazgo político ,Universidad de Salamanca (España) ,Comportamiento político ,Tesis y disertaciones académicas ,Tesis Doctoral - Abstract
Es un estudio de 25 anos (1990-2015) que toma como unidad de analisis al FREPASO y al Frente para la Victoria-kirchnerismo realizando una comparacion implicita entre ambos, asi como al interior del kirchnerismo entre las etapas de liderazgo de Nestor Kirchner y Cristina Fernandez de Kirchner, y cuenta con un trasfondo comparativo donde se observa al kirchnerismo en perspectiva comparada con los casos del Partido de los Trabajadores (PT) en Brasil y el Partido Socialista Unido de Venezuela (chavismo). Los tres casos comparten su posicionamiento contrario al neoliberalismo. El mismo titulo de la tesis encierra parte de los objetivos e hipotesis de este trabajo: ubicar al Frente para la Victoria-kirchnerismo como perteneciente al espacio politico de la centroizquierda, o izquierda reformista, en Argentina, al ocupar, en razon del desplazamiento ideologico-programatico que se produjo en el peronismo bajo el liderazgo de Nestor Kirchner, el lugar que dejo vacante el fracaso de la otra fuerza politica objeto de estudio en este trabajo: el FREPASO. De esta forma el FpV va mas alla del espacio clasico del “peronismo de izquierdas”, pues consigue rearticular una parte de militancia y voto que en su momento fue representada por el FREPASO, integrando izquierda peronista y no peronista. La dirigencia y militancia frepasista paso mayoritariamente a formar parte del espacio kirchnerista. El kirchnerismo se inscribiria en las corrientes de la denominada nueva izquierda en America Latina, que surgieron para dar respuesta a las consecuencias de las politicas neoliberales que se habian implementado en estos paises en la decada del noventa. Durante la etapa kirchnerista, el campo politico y social argentino se dividio en dos bloques antagonicos (en lo que puede observarse como la estrategia populista amigo/enemigo) . Dicha division resignifico el eje peronismo/anti-peronismo. El nuevo antagonismo se encontraria en el caracter ideologico de izquierda que adopto el kirchnerismo (peronista, populista y de izquierda). Es por ello que en el bloque anti-kirchnerista encontramos sectores del Partido Justicialista (PJ). El kirchnerismo paso a ser el punto de referencia para ubicarse en la politica argentina Para las tradiciones de izquierda que formaron parte del espacio kirchnerista la construccion de una fuerza autonoma a la estructura del PJ implicaba no estar cautivos a los desplazamientos programatico-ideologicos de este. En este punto distinguimos dos peronismos: uno ideologizado (de derecha y de izquierda) y otro pragmatico, centrista que se situa segun los desplazamientos programatico-ideologicos de quien ejerza la conduccion del partido y fundamentalmente ocupe los cargos ejecutivos en el Estado (nacional, provincial). En este sector del peronismo los incentivos selectivos (cargos en el estado, obra publica) juegan un rol central a la hora de ingresar, permanecer o abandonar la coalicion. .
- Published
- 2016
37. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?
- Author
-
Gema Fernández-Juárez, Alberto Martínez-Castelao, Enrique Gruss, Belén Vizcaíno, Verónica Escudero, Mariola D Molina, Pablo Molina, José Luis Górriz, Sandra Beltrán, Secundino Cigarrán, Juan F. Navarro-González, Ramón Romero, Ana Ávila, Elvira Fernández, Javier Nieto, Luis M Pallardó, Julia Kanter, Jordi Bover, Universidad de Alicante. Departamento de Matemáticas, and Laboratorio de Optimización (LOPT)
- Subjects
medicine.medical_specialty ,Population ,030232 urology & nephrology ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Chronic kidney disease ,Estadística e Investigación Operativa ,medicine ,Vitamin D and neurology ,Vitamin D ,Mortality ,education ,Survival analysis ,education.field_of_study ,Receiver operating characteristic ,Proportional hazards model ,business.industry ,Area under the curve ,medicine.disease ,Hospitalization ,Endocrinology ,Prospective Study ,Renal progression ,business ,Kidney disease ,Cohort study - Abstract
AIM: To evaluate thresholds for serum 25(OH)D concentrations in relation to death, kidney progression and hospitalization in non-dialysis chronic kidney disease (CKD) population. METHODS: Four hundred and seventy non-dialysis 3-5 stage CKD patients participating in OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into 3 groups according to 25(OH)D levels at enrollment (less than 20 ng/mL, between 20 and 29 ng/mL, and at or above 30 ng/mL), considering 25(OH)D between 20 and 29 ng/mL as reference group. Association between 25(OH)D levels and death (primary outcome), and time to first hospitalization and renal progression (secondary outcomes) over a 3-year follow-up, were assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. To identify 25(OH)D levels at highest risk for outcomes, receiver operating characteristic (ROC) curves were performed. RESULTS: Over 29 ± 12 mo of follow-up, 46 (10%) patients dead, 156 (33%) showed kidney progression, and 126 (27%) were hospitalized. After multivariate adjustment, 25(OH)D < 20 ng/mL was an independent predictor of all-cause mortality (HR = 2.33; 95%CI: 1.10-4.91; P = 0.027) and kidney progression (HR = 2.46; 95%CI: 1.63-3.71; P < 0.001), whereas the group with 25(OH)D at or above 30 ng/mL did not have a different hazard for outcomes from the reference group. Hospitalization outcomes were predicted by 25(OH) levels (HR = 0.98; 95%CI: 0.96-1.00; P = 0.027) in the unadjusted Cox proportional hazards model, but not after multivariate adjusting. ROC curves identified 25(OH)D levels at highest risk for death, kidney progression, and hospitalization, at 17.4 ng/mL [area under the curve (AUC) = 0.60; 95%CI: 0.52-0.69; P = 0.027], 18.6 ng/mL (AUC = 0.65; 95%CI: 0.60-0.71; P < 0.001), and 19.0 ng/mL (AUC = 0.56; 95%CI: 0.50-0.62; P = 0.048), respectively. CONCLUSION: 25(OH)D < 20 ng/mL was an independent predictor of death and progression in patients with stage 3-5 CKD, with no additional benefits when patients reached the levels at or above 30 ng/mL suggested as optimal by CKD guidelines. Abbott and the Spanish Society of Nephrology
- Published
- 2016
38. Fiscal consolidation and employment growth
- Author
-
Verónica Escudero and Elva López Mourelo
- Subjects
Labour economics ,Consolidation (business) ,Austerity ,Economic policy ,Debt ,media_common.quotation_subject ,Sustainability ,Employment growth ,Economics ,Revenue ,Fiscal union ,Social policy ,media_common - Abstract
This chapter assesses the magnitude and nature of the fiscal consolidation challenge. Indeed, while fiscal unbalances need to be addressed in the near term, countries are facing the challenge of doing so without damaging further recovery prospects and in turn public finances. In this regard, the chapter examines the evolution of fiscal balances and the recent build-up of public debt. In addition, it provides an analysis of the sustainability of public debt, putting emphasis on the medium-term effects. Moreover, the chapter looks at the recent austerity measures governments are taking with a view to consolidating public finances, so as to illustrate the manner in which governments intend to raise revenue and how they attempt to reduce expenditures during 2012. Finally, the chapter assesses the important employment and social implications of poorly designed fiscal cuts to shed light on how fiscal and employment goals can be achieved together.
- Published
- 2012
- Full Text
- View/download PDF
39. Making profits work for investment and jobs
- Author
-
Sameer Khatiwada, Verónica Escudero, and Elva López
- Subjects
Finance ,Labour economics ,business.industry ,Return on investment ,Retained earnings ,Separately managed account ,Investment style ,Umbrella fund ,Foreign direct investment ,Open-ended investment company ,business ,Investment (macroeconomics) - Abstract
Dividends, investment and their link to employment creation. Financial policies and the link to productive investment and employment.
- Published
- 2011
- Full Text
- View/download PDF
40. Are active labour market policies effective in activating and integrating low-skilled individuals? An international comparison
- Author
-
Verónica Escudero, Paris School of Economics (PSE), École des Ponts ParisTech (ENPC)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris 1 Panthéon-Sorbonne (UP1)-Centre National de la Recherche Scientifique (CNRS)-École des hautes études en sciences sociales (EHESS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Paris-Jourdan Sciences Economiques (PSE), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Recherche Agronomique (INRA)-École des hautes études en sciences sociales (EHESS)-École des Ponts ParisTech (ENPC)-Centre National de la Recherche Scientifique (CNRS), International Labour Organization (ILO), International Labour Organization, and École normale supérieure - Paris (ENS Paris)-Institut National de la Recherche Agronomique (INRA)-École des hautes études en sciences sociales (EHESS)-École des Ponts ParisTech (ENPC)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
JEL: J - Labor and Demographic Economics/J.J0 - General/J.J0.J08 - Labor Economics Policies ,Labour economics ,JEL: J - Labor and Demographic Economics/J.J6 - Mobility, Unemployment, Vacancies, and Immigrant Workers/J.J6.J65 - Unemployment Insurance • Severance Pay • Plant Closings ,J68 ,JEL: J - Labor and Demographic Economics/J.J6 - Mobility, Unemployment, Vacancies, and Immigrant Workers/J.J6.J68 - Public Policy ,jel:E24 ,Active labour market policies ,Economics ,D78 ,jel:J08 ,050207 economics ,implementation ,ComputingMilieux_MISCELLANEOUS ,JEL: E - Macroeconomics and Monetary Economics/E.E2 - Consumption, Saving, Production, Investment, Labor Markets, and Informal Economy/E.E2.E24 - Employment • Unemployment • Wages • Intergenerational Income Distribution • Aggregate Human Capital • Aggregate Labor Productivity ,050205 econometrics ,Social policy ,media_common ,participation rate ,05 social sciences ,1. No poverty ,JEL: H - Public Economics/H.H5 - National Government Expenditures and Related Policies ,[SHS.ECO]Humanities and Social Sciences/Economics and Finance ,Incentive ,H5 ,OECD ,8. Economic growth ,employment ,E24 ,Delivery system ,Aggregate level ,Low skilled ,Developed country ,Organizational Behavior and Human Resource Management ,Economics and Econometrics ,unemployment ,media_common.quotation_subject ,J08 ,startup incentives ,0502 economics and business ,ddc:330 ,JEL: E - Macroeconomics and Monetary Economics ,ALMPs ,unemployment,employment,participation rate,ALMPs,implementation,startup incentives ,labour market policy, employment policy, unskilled worker, promotion of employment, unemployment, case study, plan of action, politiques du marché du travail, politique de l'emploi, travailleur non qualifié, promotion de l'emploi, chômage, étude de cas, plan d'action, políticas del mercado de trabajo, política de empleo, trabajador no calificado, fomento del empleo, desempleo, estudio de casos, plan de acción ,Aggregate effects ,unemployment, employment, participation rate, active labour market policies, implementation, public employment services, training, start-up incentives ,Unemployment rate ,Labor policy. Labor and the state ,jel:H53 ,HD7795-8027 ,Implementation ,jel:J6 ,Industrial relations ,Unemployment ,JEL: H - Public Economics/H.H5 - National Government Expenditures and Related Policies/H.H5.H53 - Government Expenditures and Welfare Programs - Abstract
This paper examines the effectiveness of active labour market policies (ALMP) in improving labour market outcomes, especially of low-skilled individuals. The empirical analysis consists of an aggregate impact approach based on a pooled cross country and time-series database for 31 advanced countries during the period 1985–2010. A novelty of the paper is that the analysis includes aspects of the delivery system to see how the performance of ALMP is affected by different implementation characteristics. Among the notable results, the paper finds that ALMP matters at the aggregate level. Training, employment incentives, supported employment and direct job creation measures show the most favourable results, both, in terms of reduced unemployment, but also in terms of increased employment and participation. Interestingly, start-up incentives are more effective in reducing unemployment than other ALMP policies. Moreover, the positive effects seem to be particularly beneficial for the low-skilled. In terms of implementation, the paper finds that the most favourable aspect is the allocation of resources to programme administration. Finally, a disruption of policy continuity is associated with negative effects for all labour market variables analysed.
- Published
- 2015
41. MP369MINERAL METABOLISM OUTCOMES OF A TREATMENT PROTOCOL FOR CONTROLLING SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS. A PROSPECTIVE COHORT STUDY
- Author
-
Rafa Garcia-Masset, Jose E. Fernandez-Najera, Verónica Escudero, Pablo Molina, José Luis Górriz, Ana Peris, Sandra Beltrán, Juan C. Alonso-Gomez, Luis M Pallardó, Belen Alemany, Celia Climent, Laura Salvetti, and Belén Vizcaíno
- Subjects
Transplantation ,medicine.medical_specialty ,Treatment protocol ,business.industry ,medicine.disease ,Endocrinology ,Nephrology ,Chronic dialysis ,Internal medicine ,medicine ,Secondary hyperparathyroidism ,Prospective cohort study ,business ,Kidney disease - Published
- 2016
- Full Text
- View/download PDF
42. Understanding the Drivers of the Youth Labour Market in Kenya
- Author
-
Elva López Mourelo and Verónica Escudero
- Subjects
Youth unemployment ,Economic sustainability ,Vocational education ,Development economics ,Cohort ,Demographic economics ,Sociology ,Employability ,Positive Youth Development ,School attendance ,Market conditions - Abstract
This article identifies the macro and microeconomic determinants of youth unemployment and inactivity rates. It finds that although the size of the youth cohort does have significant implications for the status of youth in the labour market, aggregate labour market conditions have a greater influence. The article also finds a large gap between the youth and the overall employment elasticities in the country. This implies that fostering economic growth and ensuring economic sustainability, important as these factors are, will not be sufficient to address youth challenges. Efforts will need to be focused on improving the youth employment content of growth. In this regard, results from the microeconometric analysis find that boosting tertiary school attendance and providing targeted vocational training to young people (particularly women) would be the most effective measures for improving youth employability in the country.
- Published
- 2014
- Full Text
- View/download PDF
43. FP333WHICH FACTORS HAVE INFLUENCE ON THE MORBIDITY, INITIATION OF DIALYSIS AND MORTALITY OF PATIENTS WITH CKD STAGE 4 AND 5 NOT ON DIALYSIS? FINAL RESULTS FROM THE PECERA STUDY
- Author
-
José Luis Górriz, Belén Vizcaíno, Verónica Escudero, Luis M Pallardó, López-Menchero R, F. Javier Torralba, Pablo Molina, Josefa Martin-Rivas, Carlos Del Pozo, and Cristina Castro
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Internal medicine ,Medicine ,Stage (cooking) ,Dialysis (biochemistry) ,business - Published
- 2015
- Full Text
- View/download PDF
44. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study
- Author
-
Luis M Pallardó, Pablo Molina, Ramón Romero, Mariola D Molina, Sandra Beltrán, José Luis Górriz, Verónica Escudero, Julia Kanter, Ana Peris, Universidad de Alicante. Departamento de Estadística e Investigación Operativa, and Laboratorio de Optimización (LOPT)
- Subjects
Adult ,Male ,medicine.medical_specialty ,Urology ,Renal function ,Parathyroid hormone ,Administration, Oral ,Calcitriol receptor ,Phosphates ,chemistry.chemical_compound ,Young Adult ,Chronic kidney disease ,Estadística e Investigación Operativa ,Internal medicine ,medicine ,Vitamin D and neurology ,Albuminuria ,Humans ,Prospective Studies ,Renal Insufficiency, Chronic ,Vitamin D ,Aged ,Cholecalciferol ,Aged, 80 and over ,Transplantation ,Hyperparathyroidism ,business.industry ,Vitamins ,Middle Aged ,medicine.disease ,Vitamin D Deficiency ,Endocrinology ,chemistry ,Nephrology ,Parathyroid Hormone ,Dietary Supplements ,Disease Progression ,Female ,medicine.symptom ,business ,Kidney disease - Abstract
Background. Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods. This 6-month prospective, controlled, intervention study enrolled 101 non-dialysis CKD patients with albuminuria. Patients with low 25(OH) vitamin D [25(OH)D] and high parathyroid hormone (PTH) levels (n = 50; 49%) received oral cholecalciferol (666 IU/day), whereas those without hyperparathyroidism (n = 51; 51%), independent of their vitamin D status, did not receive any cholecalciferol, and were considered as the control group. Results. Cholecalciferol administration led to a rise in mean 25(OH)D levels by 53.0 ± 41.6% (P < 0.001). Urinary albumin-to-creatinine ratio (uACR) decreased from (geometric mean with 95% confidence interval) 284 (189–425) to 167 mg/g (105–266) at 6 months (P < 0.001) in the cholecalciferol group, and there was no change in the control group. Reduction in a uACR was observed in the absence of significant changes in other factors, which could affect proteinuria, like weight, blood pressure (BP) levels or antihypertensive treatment. Six-month changes in 25(OH)D levels were significantly and inversely associated with that in the uACR (Pearson's R = −0.519; P = 0.036), after adjustment by age, sex, body mass index, BP, glomerular filtration rate and antiproteinuric treatment. The mean PTH decreased by −13.8 ± 20.3% (P = 0.039) only in treated patients, with a mild rise in phosphate and calcium–phosphate product [7.0 ± 14.7% (P = 0.002) and 7.2 ± 15.2% (P = 0.003), respectively]. Conclusions. In addition to improving hyperparathyroidism, vitamin D supplementation with daily cholecalciferol had a beneficial effect in decreasing albuminuria with potential effects on delaying the progression of CKD.
- Published
- 2013
45. MP396VASCULARCALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4, 5 AND 5D:RECAVAS STUDY
- Author
-
Sandra Baltran, Mercedes González-Moya, Luis M Pallardó, Verónica Escudero, Jonay Pantoja, Mercedes Salgueira, José Luis Górriz, Pablo Molina, Ma Dolores Del Pino, and Cristina Castro
- Subjects
Transplantation ,medicine.medical_specialty ,business.industry ,030232 urology & nephrology ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Nephrology ,Internal medicine ,medicine ,In patient ,business ,Kidney disease - Published
- 2016
- Full Text
- View/download PDF
46. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study
- Author
-
José L, Górriz, Pablo, Molina, Jordi, Bover, Guillermina, Barril, Angel L, Martín-de Francisco, Francisco, Caravaca, José, Hervás, Celestino, Piñera, Verónica, Escudero, Luis M, Molinero, and Pedro Vidau, Argüelles
- Subjects
Male ,Cross-Sectional Studies ,Parathyroid Hormone ,Renal Dialysis ,Humans ,Kidney Failure, Chronic ,Calcium ,Female ,Phosphorus ,Guideline Adherence ,Vitamin D ,Bone and Bones ,Aged - Abstract
OSERCE is a multi-centre and cross-sectional study with the aim of analysing the biochemical, clinical, and management characteristics of bone mineral metabolism alterations and the level of compliance with K/DOQI guideline recommendations in patients with chronic kidney disease (CKD) not on dialysis. The study included a total of 634 patients from 32 different Spanish nephrology units, all with CKD, estimated glomerular filtration rates60 ml/min/1.73 m(2), and not on dialysis (K/DOQI stage: 33% stage 3, 46% stage 4, and 21% stage 5). In 409 of these patients, laboratory parameters were also measured in a centralised laboratory, including creatinine, calcium, phosphorous, intact parathyroid hormone (PTH), 25-OH-vitamin D, and 1,25-OH2-Vitamin D levels. The rates of non-compliance with the K/DOQI objectives for calcium, phosphorous, intact PTH, and calcium x phosphate product among these patients were 45%, 22%, 70%, and 4%, respectively. Of the 70% of patients with intact PTH levels outside of the target range established by the K/DOQI guidelines, 55.5% had values above the upper limit and 14.5% had values below the lower limit. Of the 45% of patients with calcium levels outside of the target range, 40% had values above the upper limit and 5% had values below the lower limit. Of the 22% of patients with phosphorous levels outside of the target range, 19% had values above the upper limit, and 3% had values below the lower limit. Finally, 4% of patients also had values for the calcium x phosphate product that were outside of the recommended range. Only 1.8% of patients complied with all four K/DOQI objectives. The values detected in centralised laboratory analyses were not significantly different from those measured in the laboratories at each institution. In addition, 81.5% of patients had a deficiency of calcidiol (25-OH-D3) (30 ng/ml); of these, 35% had moderate-severe deficiency (15 ng/ml) and 47% had mild deficiency (15-30 ng/ml). Calcitriol (1,25-OH2-D3) levels were deficient in 64.7% of patients. Whereas the calcidiol deficiency was not correlated with the CKD stage, calcitriol deficit were more pronounced at more advanced stages of CKD. The results of the OSERCE study confirm the difficulty in reaching the target values recommended by the K/DOQI guidelines in patients with CKD not on dialysis, in particular in the form of poor control of secondary hyperparathyroidism and vitamin D deficiency. With this in mind, we must review strategies for treating bone mineral metabolism alterations in these patients, and perhaps revise the target parameters set by current guidelines.
- Published
- 2012
47. FP421PROGNOSTIC SIGNIFICANCE OF THE PRESENCE OF VERTEBRAL FRACTURES IN THE SURVIVAL OF CHRONIC KIDNEY DISEASE PATIENTS STAGES 3-5 NOT ON DIALYSIS
- Author
-
Verónica Escudero, Jaume Pomés, Begoña Rivas, Ana Isabel García-Díez, José Luis Górriz, Pablo Molina-Vila, Desiree Luis, Cristina Castro-Alonso, Belén Vizcaíno, and Monserrat Del Amo-Conill
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,medicine.medical_treatment ,medicine ,business ,medicine.disease ,Dialysis ,Surgery ,Kidney disease - Published
- 2015
- Full Text
- View/download PDF
48. Renal transplantation - clinical studies - 2
- Author
-
Francisco de Assis Acurcio, Yasunaru Sakuma, M. Sigdel, Mehmet Haberal, Ana Hernández, Mukunda Prasad Kafle, Giovanni Liviano D'Arcangelo, Miklos Z. Molnar, Jorge González, D. Leonardis, Adam Remport, Torbjoern Leivestad, Francesco Gozzetti, N. Ouali, Giuseppe Montagnino, Amgad E. El-Agroudy, N. Tagieva, István Kiss, Jose Mª Morales, Laura Panicali, Elissaveta Naumova, Cristina Izzo, Maria Piera Scolari, Nicolas Collet, Lina Artifoni, Vincenzo Basile, Martin Zeier, Cristina Zanella, Maria Cristina Almeida, Mujdat Batur Canoz, Marta Novak, Valerie Garrigue, Sam Uel Lee, Delia Maria Paternoster, Andreana De Mauri, Takahisa Hiramitsu, P.F. Westeel, Emil Paskalev, K. Zandi-Nejad, K.B. Raut, Marcela Burgelova, Paolo Carta, Michela Cioni, G. Parlongo, Jean Filipov, Yoshihiko Watarai, Heloina Francisconi, Jin Kong, Loredana Alberti, Narayan Prasad, Akos Ujszaszi, Aneesh Srivastava, Saeed Akthar, Sabrina Basso, Luisa Berardinelli, Sergio Stefoni, Anne-Marie Dupuy, Jens Bollerslev, Akimasa Nakao, Anne-Sophie Bargnoux, M. Suthanthiran, A.E. Heng, Mario Rotondi, Giorgio Feliciangeli, Antonella Gurrado, Asunción Sancho, Sanja Simic-Ogrizovic, Andrea Dunai, D. Dubey, Franco Locatelli, Yu-Ji Lee, Zeljko Markovic, Diletta Conte, Matthew R. Weir, Nithya Krishnan, A. Biondo, Hans H. Hirsch, Licia Peruzzi, Katharina Hohenstein, Anastassia Mihaylova, Masahiro Yashi, Paul Cockwell, Claudia Ariaudo, Eduardo Gutiérrez, Laurynas Rimševičius, Alicja Debska-Slizien, Maria Cappuccilli, Stefano Federico, Jean-Paul Cristol, D. Kukuruga, Maria Messina, Mi Jeon, R. Lauzurica, Cibele Cesar, Elisa Ramírez, Giuseppe Stefano Netti, Amit Gupta, Giuliano Polichetti, S. Kramer, Fabrizio Ginevri, Tiziana Cena, Claudio Musetti, Carmine Zoccali, Angelica Parodi, Amado Andrés, Elisa Benetti, Manuela Della Vella, Alessandro Amore, Lara Ballerini, Piero Stratta, Giulia Ghirardo, Thais Filiponi, Giovanni Stallone, Giuseppe Paolo Segoloni, Franco Citterio, Elisabetta Bertoni, T. Ariatabar, Luisa Murer, Turan Colak, Georges Mourad, Jacopo Romagnoli, Ilona Rudminiene, Takashi Yagisawa, Jaroslav Hubacek, Angelito Rioveros, Arkadiusz Urbanowicz, Maria E. Czira, Maria Pia Rastaldi, Jin Tak Park, Eliana Parente, Pencho Simeonov, Klemens Budde, Preetham Boddana, Francesco Scolari, Anett Lindner, Roberta Giraudi, Maria Eugênia Fernandes Canziani, Eniko Sárváry, Sophie Minjolle, Kikume Ozaki, M. Cooper, Ute Eisenberger, Eva Gavela, Federica Neve Vigotti, Chong Myung Kang, Sandra Beltrán, MariaCaroline Netto, F Pietruck, Vladimir Hanzal, Paola Romagnani, Peter Hlavac, S. Seshan, Akinori Nukui, M. Delahousse, Nurhan Ozdemir, Takaaki Kobayashi, Sang Young Chung, Keitaro Yokoyama, Gerardo Oliveira, Vittorio Dalmastri, Noemie Simon, T. Becker, C. Drachenberg, Antonio Lavacca, Rajan K. Patel, Barbara Andreetta, Luisa Santangelo, Mariangela Leal Cherchiglia, F. Allano, Verónica Escudero, Alan G. Jardine, Cécile Vigneau, Lisa Burnapp, Tatsuo Hosoya, Willy Aaseboe, Nobuaki Uno, Keisuke Suzuki, Domenico Capone, Tatsuhiro Yaginuma, Massimo Sabbatini, Joseph Unsworth, D. Kalra, Marco Quaglia, Coralie Bingham, Giuseppe Cianciolo, A. Haririan, Concesa Cabanayan-Casasola, Francesca Mallamaci, Roberta Camilla, Nathalie Rioux-Leclercq, Patrick le Pogamp, Indy Dasgupta, Gulsah Sasak, Enrique Morales, Morgane Gosselin, Stepan Bandur, Duck Jong Han, M. Hakim, B R Joshi, Fernando Fachini, Giuseppe Grandaliano, Kazuharu Uchida, Glen Blake, Maura Rossetti, Marilda Mazzali, Giovanna Lunghi, Fabiana Lucio, Michal Ciszek, Luis Pallardó, Trond Jenssen, Shah-Jalal Sarkar, Edgard Bezerra, Katia Toffolo, Gunhild A. Isaksen, Stefania Bussolino, Naoshi Miyamoto, Fabrizio Fop, Gurmandeep Grewal, Irket Kadilli, H. Hurley, Antonio Leoni, Ichiro Ohkido, Claudia Sommerer, Takehito Fujiwara, Thangamani Muthukumar, Antonij Slavcev, A.N.A. vila, Osamu Muraishi, Kathryn K. Stevens, Maria Scolari, Romana Bohuslavova, Norihiko Goto, Tetsuhiko Sato, P. Reinke, Kazimierz Dziewanowski, B. Kiangkitiwan, Yudo Tanno, Andrea Buscaroli, Bruno Watschinger, Agnieszka Perkowska-Ptasinska, Jaroslav Racek, Gaetano La Manna, Anita Saxena, Hermina Konstantin, Jun Mitome, Marc Clancy, Liliana Pinho, Artur Kwiatkowski, Hiroshi Hayakawa, Natalia Polanco, Eirini Karvela, Wha Rhim Lee, Giorgia Comai, Hae Hyuk Jung, Lynsey Webb, Andrzej Rydzewski, Katalin Fornadi, Hallvard Holdaas, F. Glowacki, Petra Glander, Maria Lucia Angelotti, J.P. Rerolle, Marius Miglinas, Betul Erismis, Serena Corsini, Aline Pantano Marcassi, V. Garrigue, Ziad A Gad, Ciro Esposito, L. Couzi, Rosanna Coppo, Romina Danguilan, Daniel Constantino Yazbek, Manuel Pestana, Carla Carasi, Francesco Paolo Schena, Giancarlo Barbano, Violeta Dopsaj, Alpar S. Lazar, Daejoong Kim, Seika Kalsoom, Anna Varberg Reisæter, László Rosivall, David Goldsmith, R. Aiyer, Francesca Cofano, Burak Sayin, L. Albano, Y. Le Meur, C. Catalano, Leszek Paczek, Szilveszter Dolgos, Evaldo Favi, Jeong Jin Lee, Giuseppe Segoloni, Gabriella Beko, D. Klassen, Isabel Cristina Gomes, Masood Moghul, Valentina Cuccolo, Maciej Glyda, G. Touchard, Janka Slatinska, Vladimír Teplan, Giovanni Tarantino, Takaharu Nagasaka, Norma Cocca, Andras Szentkiralyi, Eva Honsova, José Osmar Medina Pestana, Byung Kim, Chiara Venturelli, Lionel Rostaing, J. Morales, Maurizio Salvadori, Nanae Matsuo, J. Noguiera, Cinara Sa Barros, Enrique Ona, Baik Hwan Cho, Khaled El-Dahshan, Raj Kumar Sharma, Anupma Kaul, Veronica Morellini, Visaja Lezaic, E.M. Vogel, Jin Young Kwak, Anna Rudas, R. Tripepi, Patrizia Comoli, Istvan Mucsi, G. Tripepi, Gionata Spagnoletti, Hiroyasu Yamamoto, Luigi Biancone, Loreto Gesualdo, Yoshihiro Tominaga, David M. A. Francis, Steven Harper, Antonio R. Gargiulo, Barbara Infante, Rezso Zoller, Joon Heun Jeong, Marco Castagneto, Ondrej Viklicky, Jung Lee, Dibya Singh Shah, Marek Myslak, Iris Fontana, Nobuo Ishikawa, Susumu Matsuoka, Karsten Midtvedt, Milena Stollova, Zbigniew Galazka, Antonio Dal Canton, Elena Lazzeri, Maja Vuckovic, Piergiorgio Messa, Francesca Becherucci, Nicole Lanci, Ehab W. Wafa, Stephanie Badiou, Pawan Chaliche, P. Lang, Farah Fiaz, Elisabetta Mezza, Joana Santos, W. Arns, Elaine Machado, Rakesh Kapoor, Anders Hartmann, J.P. van Hooff, and Raffaella Ribaldone
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,Medicine ,business ,Surgery - Published
- 2009
- Full Text
- View/download PDF
49. Experiencia Con Inhibidores Pcsk9 Desde Una Consulta De Nefrología
- Author
-
Quesada, Verónica Escudero, Pérez, Jonay Pantoja, Alonso, Cristina Castro, Capera, July Vanessa Osma, Antón, Alejandro Valero, and Calabuig, Asunción Sancho
- Published
- 2022
- Full Text
- View/download PDF
50. What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?
- Author
-
Molina P, Górriz JL, Molina MD, Beltrán S, Vizcaíno B, Escudero V, Kanter J, Ávila AI, Bover J, Fernández E, Nieto J, Cigarrán S, Gruss E, Fernández-Juárez G, Martínez-Castelao A, Navarro-González JF, Romero R, and Pallardó LM
- Abstract
Aim: To evaluate thresholds for serum 25(OH)D concentrations in relation to death, kidney progression and hospitalization in non-dialysis chronic kidney disease (CKD) population., Methods: Four hundred and seventy non-dialysis 3-5 stage CKD patients participating in OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into 3 groups according to 25(OH)D levels at enrollment (less than 20 ng/mL, between 20 and 29 ng/mL, and at or above 30 ng/mL), considering 25(OH)D between 20 and 29 ng/mL as reference group. Association between 25(OH)D levels and death (primary outcome), and time to first hospitalization and renal progression (secondary outcomes) over a 3-year follow-up, were assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. To identify 25(OH)D levels at highest risk for outcomes, receiver operating characteristic (ROC) curves were performed., Results: Over 29 ± 12 mo of follow-up, 46 (10%) patients dead, 156 (33%) showed kidney progression, and 126 (27%) were hospitalized. After multivariate adjustment, 25(OH)D < 20 ng/mL was an independent predictor of all-cause mortality (HR = 2.33; 95%CI: 1.10-4.91; P = 0.027) and kidney progression (HR = 2.46; 95%CI: 1.63-3.71; P < 0.001), whereas the group with 25(OH)D at or above 30 ng/mL did not have a different hazard for outcomes from the reference group. Hospitalization outcomes were predicted by 25(OH) levels (HR = 0.98; 95%CI: 0.96-1.00; P = 0.027) in the unadjusted Cox proportional hazards model, but not after multivariate adjusting. ROC curves identified 25(OH)D levels at highest risk for death, kidney progression, and hospitalization, at 17.4 ng/mL [area under the curve (AUC) = 0.60; 95%CI: 0.52-0.69; P = 0.027], 18.6 ng/mL (AUC = 0.65; 95%CI: 0.60-0.71; P < 0.001), and 19.0 ng/mL (AUC = 0.56; 95%CI: 0.50-0.62; P = 0.048), respectively., Conclusion: 25(OH)D < 20 ng/mL was an independent predictor of death and progression in patients with stage 3-5 CKD, with no additional benefits when patients reached the levels at or above 30 ng/mL suggested as optimal by CKD guidelines.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.